Industry News
CRCs' time to shine
An external review of the Cooperative Research Centres Program will be led by business leader David Miles.
[ + ]Orthocell, Antisense bolster IP portfolios
Orthocell (ASX:OTI) has been granted an Australian patent for its regenerative product Ortho-ATI, while Antisense Therapeutics (ASX:ANP) will soon obtain a European patent for ATL1102. [ + ]
Leading engineers and scientists to converge at Convention 2014
Thousands of engineers from all disciplines are coming to Melbourne for Convention 2014 - claimed to be the largest engineering event ever held in the Southern Hemisphere. [ + ]
Prestigious International Biotechnology Symposium coming down under
In a major coup for the biotechnology industry in Australia, the prestigious International Biotechnology Symposium (IBS) will be held in Melbourne in 2016 in conjunction with the AusBiotech 2016 national conference and Australia Biotech Invest 2016 - making it the largest biotech industry event in Australia's history. [ + ]
Nexvet expands veterinary biologics research team
Two former CSL (ASX:CSL) scientists have joined Nexvet's veterinary biologics research centre in Melbourne.
[ + ]Call for ideas to partner with GSK
GSK is calling for Australian and New Zealand researchers and start-up companies to submit ideas for potential partnership opportunities.
[ + ]Potential new treatment for GVHD
A potential new treatment option for bone marrow transplant patients who develop transplant-related chronic graft-versus-host disease will soon be tested in a clinical trial.
[ + ]Smooth operations with lab safety
The 2014-15 Laboratory Guide to Workplace Safety has been released. [ + ]
2014 ASI Annual Scientific Meeting
The ASI Annual Scientific meeting has joined forces with several clinically oriented societies this year to bring bench and bedside researchers together for one big immunological event. [ + ]
Global Kinetics gets FDA clearance for PKG
Global Kinetics has been cleared to sell the Australian-made Parkinson's KinetiGraph wearable symptom monitoring device in the US.
[ + ]AusBiotech calls for nominations to the board of directors
Further to the notice of the forthcoming election for AusBiotech's board of directors, nominations are now open for eligible AusBiotech members.
[ + ]Virax seeks to reactivate IND for cancer drug
Virax (ASX:VHL) has received a technical assessment that will allow it to start the process of reactivating the US IND application for cancer drug GGTI-2418.
[ + ]Iluvien approved in 10th EU market: pSivida
pSivida (ASX:PVA) licensee Alimera Sciences has got the marketing nod in Sweden for DMO treatment Iluvien, marking its 10th EU approval.
[ + ]2014 Australian Museum Eureka Prizes announced
The 2014 Australian Museum Eureka Prize winners were announced at an award dinner held last night at Sydney Town Hall. The national awards, which have been running since 1990, acknowledge outstanding contributions to Australian science. [ + ]
Bronchitol effective in high-risk bronchiectasis patients
Pharmaxis' (ASX:PXS) Bronchitol may have missed its main endpoint in last year's bronchiectasis trial, but new analysis shows a statistically significant improvement in high-risk patients. [ + ]
